In the Third Investment of 2024, What did L’Oréal Invest in?
Recently, L’Oréal, through its strategic venture capital fund BOLD, acquired a minority stake in the Swiss longevity biotechnology company Timeline. […]
Recently, L’Oréal, through its strategic venture capital fund BOLD, acquired a minority stake in the Swiss longevity biotechnology company Timeline. […]
Today, according to reports, Debut, a synthetic biology company that previously received $40 million in Series B funding from L’Oréal’s
Recently, the Hong Kong Consumer Council tested 30 popular lipstick and lip gloss brands and found that 80% of the
Today (January 17th), China’s National Bureau of Statistics released the social consumer goods retail data for December 2023. In December
Eighth Day, the luxury skin care brand founded by skin cancer surgeon Dr. Antony Nakhla, appointed Savannah Sachs as its
L’Oréal acquired a minority stake in Timeline, a Swiss longevity biotech company. The terms of this deal, facilitated through L’Oréal’s